Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 3.880
-0.060 (-1.52%)
Oct 26, 2026, 1:06 PM CET
Hyloris Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Hyloris Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of €11.23. The average 1-year stock price forecast is 189.43% higher than the current stock price, while the lowest is €6.00 (+54.64%) and the highest is €17.20 (+343.30%).
Price Target: €11.23 (+189.43%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Hyloris Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
12.16M
from 7.94M
Increased by 53.21%
Revenue Next Year
35.90M
from 12.16M
Increased by 195.18%
EPS This Year
-0.57
from -0.26
EPS Next Year
-0.49
from -0.57
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.